Literature DB >> 1735731

Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance.

T Licht1, K J Bross, H H Fiebig, K Schötta, D P Berger, C Dreher, G W Löhr, F Herrmann.   

Abstract

To compare the time course of in vitro expression of various proliferation-associated markers including Ki-67 antigen, transferrin receptors (TfR), and DNA polymerase alpha, six human tumour cell lines of different histological origin were studied under defined conditions. Proliferation markers were demonstrated by peroxidase/anti-peroxidase staining using specific monoclonal antibodies, and their expression was compared to results obtained from [3H]-thymidine incorporation assays and cell counting. Expression of all proliferation markers began to increase during the lag phase, and occurred earlier than elevations of [3H]dT incorporation and cell numbers were recorded. Maximum expression was observed before cell growth reached plateau phase. The time courses of expression of DNA polymerase and Ki-67 were almost identical. The closest correlation of [3H]dT incorporation with time course of expression of proliferation-associated markers was observed, when intranuclear staining of DNA polymerase was analysed. TfR were expressed earlier than the polymerase and Ki-67. Since TfR were also found at remarkable levels in resting cells, they seem less proliferation-specific than Ki-67 and DNA polymerase. While in rapidly growing cell lines more than 95% of the cells expressed Ki-67, TfR, and more than 75% DNA polymerase in cell nuclei, a malignant melanoma and a pleural mesothelioma line displayed fewer than 35% of cells stained for DNA polymerase in cell nuclei during log phase. Determination of growth fractions by monoclonal antibodies may thus contribute to the prediction of chemoresistance by identifying quiescent cells that are not sensitive to S-phase-specific drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735731     DOI: 10.1007/bf01187499

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  The clonogenic assay with human tumor xenografts: evaluation, predictive value and application for drug screening.

Authors:  D P Berger; H Henss; B R Winterhalter; H H Fiebig
Journal:  Ann Oncol       Date:  1990-09       Impact factor: 32.976

2.  Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry.

Authors:  H Baisch; J Gerdes
Journal:  Cell Tissue Kinet       Date:  1987-07

3.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

4.  Intracellular localization of human DNA polymerase alpha with monoclonal antibodies.

Authors:  K G Bensch; S Tanaka; S Z Hu; T S Wang; D Korn
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

5.  Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

Authors:  D W Hedley; C A Rugg; R D Gelber
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

6.  Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations.

Authors:  N A Shepherd; P I Richman; J England
Journal:  J Pathol       Date:  1988-07       Impact factor: 7.996

7.  Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase.

Authors:  A Alama; P F Conte; E Di Marco; R E Favoni; A Nicolin
Journal:  Oncology       Date:  1986       Impact factor: 2.935

8.  Prognostic implications of ploidy and proliferative activity in human solid tumors.

Authors:  B Barlogie; D A Johnston; L Smallwood; M N Raber; A M Maddox; J Latreille; D E Swartzendruber; B Drewinko
Journal:  Cancer Genet Cytogenet       Date:  1982-05

9.  Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential.

Authors:  S D Young; R P Hill
Journal:  J Natl Cancer Inst       Date:  1990-03-07       Impact factor: 13.506

10.  Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase alpha.

Authors:  A Yamaguchi; S Takegawa; T Ishida; G Nishimura; M Kato; M Kanno; T Kosaka; Y Yonemura; I Miyazaki
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

View more
  4 in total

1.  Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma.

Authors:  Da-Wei Li; Shang Gao; Bin Shen; Pin Dong
Journal:  Med Oncol       Date:  2010-09-23       Impact factor: 3.064

Review 2.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

3.  Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.

Authors:  M Kiehntopf; M A Brach; T Licht; S Petschauer; L Karawajew; C Kirschning; F Herrmann
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

4.  Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells.

Authors:  Yukiko Miyatake; Yusuke Ohta; Shunji Ikeshita; Masanori Kasahara
Journal:  Oncotarget       Date:  2018-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.